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Using deep RNA sequencing, we have studied the expression of adenovirus-encoded small RNAs at
different times after infection. Nineteen small RNAs which comprised more than 1% of the total pool of
small RNAs at least one time point were identiﬁed. These small RNAs were between 25 and 35
nucleotides long and mapped in the region of the VA RNAI and RNAII genes. However, the overlap was
incomplete and some contained a few extra nucleotides at the 3' end. This ﬁnding together with the
observation that some of the small RNAs were detected before VA RNA expression had started might
indicate that they are derived from other precursors than VA RNAI and II. Interestingly, the small RNAs
displayed different expression proﬁles during the course of the infection suggesting that they have
different functions. An effort was made to identify their mRNA targets by using computer prediction and
deep cDNA sequencing. The most signiﬁcant targets for the earliest small RNAs were genes involved in
signaling pathways.
& 2013 Elsevier Inc. All rights reserved.Introduction
Human adenoviruses are non-enveloped icosahedral viruses
with linear double stranded DNA genomes of 30–38 kb. The
genome is transcribed from both strands and it is organized into
several transcription units named mainly according to when they
are expressed during the virus life cycle (Davison et al., 2003). Five
early transcription units encode the E1A, E1B, E2, E3 and E4
proteins, two delayed early units encode the IVa2 and pIX proteins
and there is one major late transcription unit (MLTU). The major
functions of the early gene products are to force the host cell to
enter the S phase (Bayley and Mymryk, 1994; Cobrinik, 1996) in
order to provide optimal conditions for viral DNA replication and
for suppression of the host antiviral response (Wold et al., 1994).
The major late gene products are the viral structural proteins
which package the viral DNA into new virus particles. Group C
adenoviruses also encode two small RNAs, called virus-associated
(VA) RNAI and VA RNAII (Akusjarvi et al., 1980; Mathews, 1975;
Pettersson and Philipson, 1975; Price and Penman, 1972; Reich
et al., 1966). They are non-coding RNAs and transcribed by RNA
polymerase III (Ma and Mathews, 1996; Weinmann et al., 1974).
Both VA RNAs are about 160 nucleotides long and GC rich.
Expression of the VA RNAs begins during the early phase of
infection and increases rapidly to a high level during the late
phase (Reich et al., 1966; Soderlund et al., 1976). VA RNAI is thell rights reserved.
).most abundant species and accounts for 95% of the total VA RNA
pool. Inactivation of VA RNAI in adenovirus type 5 results in a 10–
20 fold decrease in virus production, whereas deletion of VA RNAII
alone has little impact on virus replication (Thimmappaya et al.,
1982). Thus, the functional signiﬁcance of VA RNAI is well
documented whereas little is known about the function of VA
RNAII. The primary function of VA RNAI appears to be to block the
activity of RNA-dependent protein kinase (PKA), a double-strained
RNA activated inhibitor of translation (Akusjarvi et al., 1987;
Ghadge et al., 1991; Maran and Mathews, 1988; O’Malley et al.,
1986). PKA is an interferon-inducible serine-threonine protein
kinase which phosphorylates the eukaryotic initiation factor 2
(eIF-2) resulting in the inhibition of cellular protein synthesis
(Kitajewski et al., 1986; Levin et al., 1980; Petryshyn et al., 1983). It
provides a potent anti-viral defense mechanism. VA RNAI also
stabilizes ribosome-associated viral mRNAs resulting in enhanced
levels of viral protein synthesis (O’Malley et al., 1989). In addition,
VA RNAI binds efﬁciently to Exportin 5 (Exp5), thus interfering
with the nuclear export of the cellular RNAi and miRNA precursors
and Dicer processing (Andersson et al., 2005; Lu and Cullen, 2004).
Finally, large amounts of VA RNA-derived small RNAs associate
with RNA-induced silencing (RISC) complexes (Xu et al., 2009).
The VA RNAs fold into a stable stem-loop structure which is
similar to that of pre-miRNAs and are subjected to a similar
processing (Ma and Mathews, 1993, 1996; Pe’ery et al., 1993).
The structure can be divided into three regions: the panhandle
apical stem, a more structured central domain, and the terminal
stem. The termini of both VA RNAI and II are heterogeneous, due
to variable transcription initiation and termination sites. VA RNAI
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at nt 10610 VA RNAI(G)] (Xu et al., 2009). The latter is the major
species and accounts for 75% of the total pool of VA RNAI. It has
been demonstrated in vitro and in vivo that 2–5% of the VA RNAs
are cleaved by Dicer in their terminal stem generating small viral
RNAs named svaRNAs or mivaRNAs (Andersson et al., 2005;
Aparicio et al., 2006). The most prominent mivaRNAs are made
from the 3' ends of VA RNAI and VA RNAII and named after their
starting positions (Xu et al., 2007). Most abundant are mivaRI-137
(nt 10746) and -138 (nt 10747) processed from VA RNAI and
mivaRII-138 (nt 11003) from VA RNAII. These small RNAs are
efﬁciently incorporated into the RISC complex. It has been shown
that 80% of RISC-bound miRNA at the late phase of infection is
mivaRNA (Andersson et al., 2005; Mathews, 1995). Thus the RISC
function seems to be under the control of Ad mivaRNA. The
mivaRNAs are also produced from the 5’ end of VARNAI albeit at
a very low level and the incorporation into the RISC complex is
inefﬁcient (Xu et al., 2007).
During the last decade, increasing numbers of small RNAs have
been identiﬁed and characterized and it has become evident that
the small RNAs are critical regulators of gene function (Bartel,
2004; Seto et al., 2007; Zaratiegui et al., 2007). There are three
main categories: short interfering RNAs (siRNAs which are ∼21 nt
in length), microRNAs (miRNAs, ∼22 nt in length) and PIWI-
interacting RNAs (piRNAs, ∼24–32 nt in length) (Farazi et al.,
2008). siRNAs and miRNAs are present in a broad range of
eukaryotic species and are characterized by the double-stranded
nature of their precursors (Ruby et al., 2006). In contrast, piRNAs
are primarily found in mammals and exert their function in the
germ line (Kim, 2006). They are processed from single-stranded
RNA precursors and transcribed mainly from repetitive elements
known as piRNA clusters by a Dicer-independent pathway. miR-
NAs act as key post-transcriptional regulators of gene expression,
through modulating the translational efﬁciency and/or the stabi-
lity of target mRNAs. In addition to eukaryotes, several virus
families have been shown to encode small RNAs. Five Epstein-
Barr virus-encoded premiRNAs were identiﬁed in infected cells
(Pfeffer et al., 2004). Subsequent studies identiﬁed a total of 25
pre-miRNAs, which produce at least 44 mature miRNA species (Cai
et al., 2006; Grundhoff et al., 2006; Zhu et al., 2009). Furthermore,
many herpes viruses have been shown to encode miRNAs (Cai
et al., 2005; Grundhoff et al., 2006; Pfeffer et al., 2005). These are
derived from structured single stranded transcripts and thus
deﬁned as virus-encoded miRNAs. They are believed to regulate
the expression of speciﬁc viral and cellular mRNAs. In addition,
virus-encoded miRNAs or miRNA-like RNAs have been identiﬁed
in many viruses including members of the polyomavirus family,
Dengue virus, vesiclar stomatitis virus, baculovirus, hepatitis C
virus, West Nile virus, and human immunodeﬁciency virus
(Aparicio et al., 2006; Cantalupo et al., 2005; Hussain et al.,
2008; Parameswaran et al., 2010; Schopman et al., 2012; Seo
et al., 2009; Singh et al., 2010; Sullivan et al., 2005).
Deep sequencing technologies combined with bioinformatic stra-
tegies have revolutionized the identiﬁcation of rare small RNAs. In
this study, we have studied the expression of adenovirus-encoded
small RNAs at different times after infection using the SOLid deep
sequencing technology.Materials and methods
Cell culture and adenovirus infection
Human primary lung ﬁbroblast cells (IMR-90) (American Type
Culture Collection) were cultured in Eagle's minimum essential
medium (MEM) with Earle's salt and GlutaMAX™ supplementedwith 10% fetal bovine serum, 100 U/ml penicillin, 100 mg/ml
streptomycin, 0.1 mM nonessential amino acids, 1.5 g/L sodium
bicarbonate and 1.0 mM sodium pyruvate. After reaching conﬂu-
ence, the cells were cultured for two more days in order to
synchronize the cells. Over 95% of the cells were in the G0/G1
phase as indicated by FACS analysis (Zhao et al., 2007). Synchro-
nized monolayer cells were mock-infected or infected with Ad2 at
a multiplicity of 100 ﬂuorescence-forming units (FFU) per cell
(Philipson, 1961) in serum-free medium. After 1 h adsorption at
37 1C, the medium was replaced with MEM containing 10% FBS
and incubated at 37 1C. Infected cells were collected at 6, 12, 24,
and 36 h post infection (hpi). Mock-infected cells were collected
at 6 hpi.
RNA extraction, cDNA library preparation, and sequencing
Total RNA from adenovirus or mock-infected IMR-90 cells was
extracted using TRIZOL Reagent (Invitrogen). The quality of the
input RNA in the 10–40 nt size range was controlled using the RNA
6000 Pico chip on a Bioanalyzer (Agilent Technologies). Only RIN-
values above 7 were accepted. Enrichment of the small RNA was
done by using the Invitrogen PureLink miRNA Isolation Kit
according to the manufacturer's protocol. Small RNA libraries were
constructed using the SOLiD Total RNA-Seq Kit (Rev B, Life
Technologies). Strand speciﬁc adapters were hybridized to the
RNA before reverse transcription. The cDNAwas then size-selected
on a 10% TBE- Urea gel (Life Technologies) and the libraries were
constructed after ampliﬁcation (15 cycles). Emulsion PCR was
performed using the EZ Bead System (Life Technologies) and the
small RNA libraries were then sequenced on the SOLiD 5500xl
system (35 bp read length, Life Technologies).
Data collection and mapping of reads
The reads were generally longer than the investigated RNAs
because of possible remains of the adapter sequence. We used a
strict algorithm to ﬁnd the maximal overlap between the 3’-
adapter and the end of the read. The trimmed reads of each
library were then aligned to the whole genome sequence of
human adenovirus type 2 (http://www.ncbi.nlm.nih.gov/nuccore/
NC_001405.1) using the Map reads module of LifeScope 2.5 soft-
ware (http://www.lifetechnologies.com/lifescope). Here we allowed
two mismatches.
Identiﬁcation of adenovirus-encoded small RNA
The read alignments were rigorously checked for quality. First
we removed the reads mapping to the Coding DNA Sequence
(CDS) regions. After sorting the reads by their expression number,
small RNAs were collected if they have high predominance and
change with time. We found that nearly all reads were exclusively
located within the VA RNA region.
Prediction of adenovirus-encoded small RNA targets and function
enrichment analysis
Potential cellular gene targets of adenovirus-encoded small
RNAs were predicted by using RNAhybrid (http://bibiserv.techfak.
uni-bielefeld.de/rnahybrid/) using the reference human gene set
(hg19). The target gene list was then cleaned by ﬁltering through
the Support Vector Machines (SVM) model.
The web based software DAVID (Huang da et al., 2009a, 2009b)
was used to perform a gene ontology enrichment analysis of the
differentially expressed genes. The annotated genes from the
RefSeq data set were used as background. This analysis sear-
ched for biochemical pathways and gene ontologies that were
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AIdentiﬁcation of adenovirus-encoded RNAs by cDNA sequencing
Previously, we have studied the transcriptional proﬁles in adeno-
virus infected IMR-90 cells. Three cDNA libraries, prepared from
mock, Ad2 infected cells at 12 (Ad2-12hpi) and 24 (Ad2-24hpi)
hours after infection were sequenced and generated 50–54
million 76 bp long sequence reads per sample. Deregulation of
cellular mRNA expression was the main focus in our previous
publication (Zhao et al., 2012). This study also generated a
comprehensive data set of adenovirus gene expression. Among
detected sequence reads, 4.4% at 12 hpi and 45% at 24 hpi could
be mapped to the adenovirus genome. At 12 hpi, only adenovirus
early genes E1A, E1B, E3, E4 and E2A were expressed. Following
the progress of the infection, adenovirus gene expression was
dramatically changed and transcripts from the major late tran-
scription unit (MLTU) became very abundant. An interesting
ﬁnding was that RNA transcripts spanning from 10700 to 10800
were the most abundant and reached more than 180,000 reads.
This region covers the VA RNA genes and we suspected that the
peak could contain a pool of small RNAs. To test the hypothesis,
we performed small RNA sequencing.2. Detection of adenovirus-encoded RNAs in the 10–35 nt range
by RNA sequencing
The small RNA pool in adenovirus infected IMR-90 cells was
sequenced by SOLiD sequencing technology. Hereby, the
expression of miRNAs and other non-coding RNAs of both
cellular and viral origin could be discovered and proﬁled in
an unbiased way. In the present study we focused on the
expression of adenovirus-encoded small RNAs. Sequencing was
performed on ﬁve RNA samples extracted from mock and
adenovirus infected cells at 6, 12, 24 and 36 hpi. As shown in
our previous study, these time points represent different stages
of the infectious cycle, i.e. before any adenoviral gene expres-
sion, immediate early gene (E1a) expression, adenoviral DNA
replication and viral late gene expression, respectively (Zhao
et al., 2007). Thus, we could correlate the expression of small
RNAs with the progression of the infection.
The expression of adenovirus-encoded small RNAs increased
rapidly after infection. There were 97,408, 844,458, 1,866,214
and 4,566,034 sequence reads that could be mapped to
adenovirus genome at 6, 12, 24 and 36 hpi, respectively
(Table 1). It is noteworthy that the most dramatic increase,
approximately 9-fold, occurred between 6 and 12 hpi. Then,
there was a relative steady increase of about 2-fold from 12 to
24 and from 24 to 36 hpi. More than 98% of the adenovirus-
encoded small RNAs were mapped within the VA RNAI and VA
RNAII region at 6 hpi, which was then slightly decreased
to 89.6% at 36 hpi. The majority of small RNAs was mapped
within the VA RNAI region. Using 1000 sequence reads as a cut-
off level, 207 small RNAs were identiﬁed (see Table inle 1
mary of alignment of sequence reads to the adenovirus genome.
Mock 6 hpi
eq Reads aligned to Ad 680 97408
ligned to VA RNAI and II (% to the total Ad small RNA) 561 96075 (98.
ligned to VA RNA I (% to the total VA RNAs) 453 76750 (80%
ligned to VA RNAII (% to the total VA RNAs) 108 19325 (20%
d encoded small RNA with 41000 reads 7supplementary material). Nearly all of them (205 out of 207)
were mapped to the VA RNAI and VA RNAII regions as shown in
Fig. 1. Included in this ﬁgure is the expression of unfractionated
adenovirus RNA at 24 hpi (blue curve) detected by cDNA
sequencing of total RNA. The locations of the previously
identiﬁed adenovirus speciﬁc mivaRNAs are also shown
(Andersson et al., 2005; Sano et al., 2006; Xu et al., 2007).
The majority of the adenovirus-encoded small RNAs co-
localized with the highly expressed VA RNAI. There were four
major groups of small RNAs. All small RNAs in each group
overlap but vary in length at the 5′ or 3′ end or both. The small
RNAs in the ﬁrst groups comprise two major clusters which
differ from each other by three nt at the 5’ end, corresponding
to the transcription initiation sites for VA RNAI(G) and VA RNAI
(A). Surprisingly, more than 60% of detected small RNAs were
mapped to the region spanning from the central domain to the
3’ end of VA RNAI (nt 10702 to 10772). These RNAs were very
heterogeneous at both the 5’ and the 3’ ends. Less than 30% of
the small RNAs mapped to the VA RNAII region. One cluster
contained RNAs with identical 5’ ends matching the initiation
site of VA RNAII. Another cluster which mapped to the 3’ end of
VA RNAII was heterogeneous at both the 5’ and the 3’ ends
spanning a region from nt 10968 to 11030.
The length of the small RNAs ranged from 25 to 35 nt (as
shown in Fig. 2 and Table in supplementary data). The most
signiﬁcant group was 35 nt long. However, it is possible that
this group included longer RNAs, since the sequence reads were
only 35 nt long. Therefore, we were unable to determine the 3’
end of these RNAs unambiguously. A surprising ﬁnding was
that several of small RNAs have 3´ends which extend beyond
the 3´ends of VARNAI and II.3. Expression of distinct sets of small RNA at different stages of
the infectious cycle
Fig. 3 shows the alignment of small RNAs expressed at different
times after infection to the VA RNA gene region. At 6 hpi, when
E1A expression could barely be detected, a signiﬁcant amount
of small RNAs was identiﬁed mapping to the 5’ end of VA RNAI
(with more than 53,000 reads). To reveal the expression
difference, the relative abundances of the adenovirus-encoded
small RNAs were calculated for each small RNA species in
relation to the total pool of all detected adenovirus-encoded
small RNAs at each time point. Small RNAs with more than 1%
value were considered as signiﬁcantly expressed and included
in Table 2. At 6 hpi, the most abundant small RNA (54.6%) maps
to 5’ end of VA RNAI, from nt 10607 to 10631 (VA sRNA10607–
10631). Two small RNAs (VA sRNA10866–10896 and VA sRNA10866–
10897) which mapped to the 5’ end of VA RNAII represented the
second most abundant small RNAs (7.9%). Remaining RNAs
mapped mostly to the 3’ end of VA RNAI and VARNAII. At 12
hpi, the overall expression of small RNAs increased 9-fold.
Expression of VA sRNA10607–10631 was increased 10-fold and
accounted for 63.5% of adenovirus-encoded small RNAs at this
time. Although the small RNAs that mapped to the 3’ end of VA
RNAI was increased 3-fold, they represented less than 1% of the
small RNAs at this time point. Small RNAs mapping to VA RNAII,12 hpi 24 hpi 36 hpi
844458 1866214 4566034
6%) 794399 (94.1%) 1687552 (90.4%) 4092903 (89.6%)
) 594323 (75%) 1170338 (69%) 3706951 (91%)
) 200076 (25%) 517214 (31%) 385952 (9%)
35 116 177
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Fig. 1. Overlap between adenovirus-encoded small RNAs and the most highly expressed RNA from the adenovirus genome as measured by cDNA sequencing. Expression of
adenovirus RNAs in the region from 10600 to 11050 at 24 hpi is indicated by the blue curve. The region from 10706 to 10776 is the most highly expressed RNAs from the
adenovirus genome. Adenovirus-encoded small RNAs, covered by more than 1000 reads (at any time point) are shown by the red horizontal bars. The locations of VA RNAI
and II, as well as previously identiﬁed adenovirus-encoded small RNAs are indicated by green lines at the bottom of the ﬁgure.
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Fig. 2. Size distribution of adenovirus-encoded small RNAs which were covered by
more than 1000 sequence reads (at any one of the time points). The numbers and
the length of small RNAs are indicated above and under the bars, respectively.
H. Zhao et al. / Virology 442 (2013) 148–155 151especially to the 3’ end, were also increased (about 10% in
total). About 5.7% of the small RNAs mapped to the 5’ end of VA
RNAII. The change of the expression proﬁle at 24 hpi was
dramatic. The fraction of VA sRNA10607–10631 decreased to 28.4%.
Instead, small RNAs that mapped to the 3´ side of the central
domain of VA RNAI from 10702 to 10736 (or longer) increased
at 24 hpi (12.7% in total) and became the most abundant class
at 36 hpi (49.2% in total). In addition, a group of small RNAsthat mapped to the 3’ end of VA RNAII reached its highest level
(416.6%) at 24 hpi, but was decreased at 36 hpi.
Prediction of small RNA targets
The possible functions of the small RNAs were studied by
prediction of their potential targets using RNAhybrid, which is a
tool for ﬁnding the minimum free energy of hybrids between
long mRNAs and small RNAs. The identiﬁed potential target
mRNAs were then subjected to functional enrichment analysis
by using gene functional annotation resources (DAVID). Three
highly expressed small RNAs, Ad VA sRNA10607–10731, Ad VA
sRNA10702–10736 and Ad VA sRNA11001–11025, were chosen for this
analysis, because of their abundance and their expression
kinetics. The results showed that the predicted targets of Ad VA
sRNA10607–10731 were involved in various signaling pathways, cell
surface structure, and ligand-receptors interaction (Table 3). In
contrast, the predicted target genes of Ad VA sRNA11001–11025
were mainly involved in cellular metabolic pathways such as
nitrogen metabolism, glycan biosynthesis, and fatty acid bio-
synthesis. No signiﬁcant cellular targets were predicted for Ad VA
sRNA10702–10736 perhaps because of its length. As a step further,
we compared the predicted target genes with genes that were
found to be deregulated in our previous study (Zhao et al., 2012).
Interestingly our previous study showed that cellular signaling
pathways were the most signiﬁcantly suppressed gene group at
12 hpi. The most signiﬁcant class of predicted targets of Ad VA
sRNA10607–10731 was various protein kinases (Table 4). These
kinases participate in several signaling pathways that are
involved in cellular stress/immune response and apoptosis, (such
as MAP kinases: MAPKAPK2 MAP3K14 and MAP2K4, serine/
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Fig. 3. A compilation of adenovirus-encoded small RNAs within the VA RNA region at 4 different time points after infection. Each small RNA was aligned to the VA RNA
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Table 2
Expression of adenovirus-encoded small RNAs with more than 1% of the total pool at different stages of infection.
Genome location Sequence reads Percentage to the total pool
Mock 6 hpi 12 hpi 24 hpi 36 hpi 6 hpi 12 hpi 24 hpi 36 hpi Length
VA RNAI 10607-10631 92 53211 536412 529337 660156 54.6 63.5 28.4 14.5 25
10702-10731 9 24 38 5948 44023 0.0 0.0 0.3 1.0 30
10702-10733 14 95 280 16577 158629 0.1 0.0 0.9 3.5 32
10702-10734 10 79 196 8472 85711 0.1 0.0 0.5 1.9 33
10702-10735 18 43 245 9201 90334 0.0 0.0 0.5 2.0 34
10702-10736 149 261 800 196241 1861215 0.3 0.1 10.5 40.8 35
10723-10757 5 83 91 4401 56325 0.1 0.0 0.2 1.2 35
10730-10754 2 1575 1915 8080 10731 1.6 0.2 0.4 0.2 25
10747-10771 10 1743 5079 40884 9530 1.8 0.6 2.2 0.2 25
10747-10772 4 561 2470 72684 3366 0.6 0.3 3.9 0.1 26
VA RNAII 10866-10890 6 550 18463 44027 9513 0.6 2.2 2.4 0.2 35
10866-10896 3 2068 6190 2117 901 2.1 0.7 0.1 0.0 31
10866-10897 12 5664 23351 5370 1432 5.8 2.8 0.3 0.0 32
11001-11025 2 1199 29483 94717 150033 1.2 3.5 5.1 3.3 25
11001-11026 4 273 7246 29752 46401 0.3 0.9 1.6 1.0 26
11002-11026 0 751 15974 106591 27836 0.8 1.9 5.7 0.6 25
11002-11030 0 129 2030 22334 6583 0.1 0.2 1.2 0.1 29
11003-11027 4 1236 35090 56744 18429 1.3 4.2 3.0 0.4 25
Table 3
Functional enrichment of small RNA targets by DAVID analysis.
prediction target of VA sRNA10607–
10631
Predicted target of VA sRNA11001–
11025
Calcium signaling pathway Nitrogen metabolism
MAPK signaling Glycan synthesis
Focal adhesion Glycosphingolipid biosynthesis
Gap junction Adipocytokine signaling pathway
ECM-receptor interaction Fatty acid biosynthesis/metabolism
ErbB signaling pathway Metabolic pathway
Insulin signaling pathway Lysosome
Long-term depression ECM-receptor interaction
GnRH signaling pathway TGF-beta signaling pathway
H. Zhao et al. / Virology 442 (2013) 148–155152threonine kinase: STK17A, and STK40, as well as NUAK2 and
LAST2), growth/cell cycle arrest (such as AURKA, PLK3, RPS6KA2,
STK10 and SPEG) and cytoskeletal organization, vesicle trafﬁcking
and nuclear transport (DCLK2, DMPK, SGK223, MAST4, PAK4 and
WNK4). Furthermore, numerous small GTPases (RAB4B, RAB22A,
RAB2B, RAB40C, RAB5B, RAB6C, ARF4 and RND3) and their
regulators, GTPase-activating proteins (EVI5L, TBC1D2,
TBC1D10B, TBC1D23 and TBC1D10A) and guanine nucleotide
exchange factors (ARHGEF39, ARHGEF40, PLEKHG4, PLEKHG2
and ARHGEF17) were found among the target genes. It is more-
over noteworthy that most of these genes were down-regulated
already at 12 hpi. Taken together the results indicated that the
immediately expressed small RNAs target cellular signaling
Table 4
Functional enrichment of down-regulated genes that were predicted as Ad VA sRNA10607–10631 targets.
Symbol Gene name Fold change P-val
12 hpi 24 hpi
Group 1 enrichment score: 4.2 AURKA Aurora kinase A −3.6a −6.0 0
Csnk1g3 Casein kinase 1, gamma 3 −1.4 −3.0 3.2E-111
clk1 CDC-like kinase 1 −1.4 −2.0 3.73E-69
Dclk2 Doublecortin-like kinase 2 −2.2 −3.3 5.9E-105
DMPK Dystrophia myotonica-protein kinase −1.6 −2.4 0
SGK223 Homolog of rat pragma of Rnd2 −1.7 −3.7 1.3E-141
Lats2 LATS, large tumor suppressor, homolog 2 (Drosophila) −1.9 −3.2 5.1E-227
MAST4 Microtubule associated serine/threonine kinase family member 4 −1.6 −2.7 8.01E-85
MAP2K4 Mitogen-activated protein kinase kinase 4 −1.2 −2.1 1.39E-25
MAP3K14 Mitogen-activated protein kinase kinase 14 −1.8 −2.1 1.44E-28
MAPKAPK2 Mitogen-activated protein kinase-activated protein kinase 2 −1.7 −3.2 0
NEK3 NIMA (never in mitosis gene a)-related kinase 3 −2.1 −9.1 4.86E-61
NUAK2 NUAK family, SNF1-like kinase, 2 −3.4 −14.0 5.1E-241
PAK4 p21 protein (Cdc42/Rac)-activated kinase 4 −1.2 −2.0 2.2E-137
Cdk17 PCTAIRE protein kinase 2 −1.4 −3.3 9.76E-56
plk3 Polo-like kinase 3 (Drosophila) −1.5 −8.0 5.3E-173
RPS6KA2 Ribosomal protein S6 kinase, 90 kDa, polypeptide 2 −1.5 −2.6 0
STK10 Serine/threonine kinase 10 −1.3 −2.9 7E-120
STK17A Serine/threonine kinase 17a −1.7 −4.8 3E-149
STK36 Serine/threonine kinase 36, fused homolog (Drosophila) −1.1 −2.5 1.91E-42
Stk40 Serine/threonine kinase 40 −1.5 −3.0 4.29E-98
speG SPEG complex locus −1.1 −4.0 3.7E-158
WNK4 WNK lysine deﬁcient protein kinase 4 −1.1 −6.9 1.21E-71
Group 2 enrichment score: 3.9 EVI5L Ecotropic viral integration site 5-like −1.0 −2.1 2.14E-88
TBC1D2 TBC1 domain family, member 2 −2.5 −14.7 0
TBC1D10B TBC1 domain family, member 10B −1.2 −2.2 9.01E-85
TBC1D23 TBC1 domain family, member 23 −1.2 −2.4 4.3E-29
TBC1D10A TBC1 domain family, member 10A −2.0 −8.7 6.6E-99
Group 3 enrichment score: 3.8 ARHGEF39 Rho guanine nucleotide exchange factor (GEF) 39 −1.6 −3.4 1.72E-36
ARHGEF40 Rho guanine nucleotide exchange factor (GEF) 40 −1.2 −2.3 8.5E-135
PLEKHG4 Pleckstrin homology domain containing, family G (with RhoGef domain) member 4 −1.7 −3.8 0
PLEKHG2 Pleckstrin homology domain containing, family G (with RhoGef domain) member 2 −1.2 −3.6 7.5E-274
ARHGEF17 Rho guanine nucleotide exchange factor (GEF) 17 −1.4 −4.3 0
Group 4 enrichment score: 1.7 RAB4B member RAS oncogene family −1.4 −4.2 6.24E-37
RAB22A member RAS oncogene family −1.3 −3.3 1.41E-62
RAB2B member RAS oncogene family −1.3 −2.3 3.31E-41
RAB40C member RAS oncogene family −0.9 −2.0 7.16E-28
RAB5B member RAS oncogene family −1.0 −2.3 2.4E-117
RAB6C member RAS oncogene family; −1.0 −3.3 3.89E-27
ARF4 ADP-ribosylation factor 4 −1.3 −2.8 8.64e-316
RND3 Rho family GTPase 3 −2.4 −7.5 0
Group 5 enrichment score: 1.3 KCTD13 potassium channel tetramerisation domain containing 13 −1.7 −3.1 7.72E-58
KCTD9 similar to Potassium channel tetramerisation domain containing 9; −1.7 −3.8 1.42E-67
KCTD11 potassium channel tetramerisation domain containing 11 −1.5 −3.8 2.7E-101
KCTD21 potassium channel tetramerisation domain containing 21 −1.2 −3.4 9.88E-40
KCTD5 potassium channel tetramerisation domain containing 5 −2.6 −3.5 3E-144
KCNF1 potassium voltage-gated channel, subfamily F, member 1 −1.5 −10.4 2.95E-43
KCNG1 potassium voltage-gated channel, subfamily G, member 1 −1.7 −2.1 1.83E-95
TNFAIP1 tumor necrosis factor, alpha-induced protein 1 (endothelial) −2.0 −3.2 5.1E-247
a The change (fold) of mRNA expression in adenovirus-infected cells as compared to mock-infected cells measured by cDNA sequencing.
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growth/cycle and intracellular transport.Discussion
The aim of the present study was to perform a comprehensive
and unbiased study of small adenovirus-encoded RNAs. More than
200 small RNAs were identiﬁed using 1000 reads as the cut off
level. Many of them were overlapping and differed because of
heterogeneity at both the 3’ and 5’ ends and only 19 of them
comprised more than 1% of the total pool of small RNAs at any time
point. Between 90 and 98% of the reads mapped in the VA RNA
region. Remaining reads were spread over the genome and each
species accounted for a minor fraction of all reads. Surprisinglynone of the small RNAs identiﬁed here were identical to the
previously detected adenovirus-encoded small RNAs (mivaRNAI-
137, -138 and mivaRNAII-138). We did detect small RNAs that
overlapped with them, but they were 2–15 nt longer at ehiter the
3’ or 5’ end. The small RNAs identiﬁed here were longer than most
well deﬁned cellular small RNAs, such as miRNA and siRNA. It
could be argued that our sequencing procedure failed to detect
RNAs less than 25 nt long. This seems however, unlikely since we
did detect expression of more than 300 annotated cellular miRNAs.
For instance, microRNA 21 was covered by more than 10,000 reads.
One possibility is that adenovirus utilizes a unique mechanism for
generating small RNAs. A noteworthy difference is that adenovirus
VA RNAI and II are synthesized by pol III.
A striking ﬁnding was that the expression of different
adenovirus-encoded small RNAs increased and declined during
H. Zhao et al. / Virology 442 (2013) 148–155154different phases of the infection. At 6 hpi, VA sRNA10607–10631 was
the most highly expressed species. It may represent the earliest
adenovirus gene expression, since no expression of other adeno-
virus genes has been detected at this time point in IMR-90 cells
(Zhao et al., 2007). It is tempting to speculate that this RNA plays
an important role during the very early phase of infection. To gain
support for this hypothesis, we performed a target predication and
the results suggested that mRNAs encoding proteins in signaling
pathways are the targets. In line with this we have shown before
by deep cDNA sequencing (Zhao et al., 2012) that the most
signiﬁcantly suppressed gene group at 12 hpi was implicated in
cell signaling pathways. The predicted targets included various
kinases, small GTPases and their regulators, guanine nucleotide
exchange factors and GTPase-activating proteins. Among them p38
MAPK is noteworthy since MAPKs mediate responses to a diverse
array of stimuli, including virus infection. The main downstream
target genes regulate proliferation, cell survival and apoptosis, cell
growth/cell cycle arrest and cytoskeleton. In fact, immediate
activation of several cellular signaling pathways, such as PKA
and p38/MAPK have been reported (Suomalainen et al., 2001).
When the infection progressed, a dramatic change in the small
RNAs expression proﬁle occurred. VA sRNA10607–10631 was no
longer dominant. Instead expression of a new small RNA, VA
sRNA10702–10736, mapping to the central domain of VA RNAI
became the most dominant species. Expression of this small RNA
correlated with the onset of adenovirus DNA replication as well as
capsid protein synthesis. Thus it could be speculated that it is
involved in positive regulation of cellular metabolism to secure
maximal production of progeny. We did perform target prediction
for this RNA, but no signiﬁcant target was predicted, probably due
to the length of this small RNA. Relative to the expression of small
RNAs that mapped to the VA RNAI region, the expression of small
RNAs that mapped to the VA RNAII region was low and their
kinetics were different. At 24 hpi expression of VA sRNA10607–10631
declined and expression of VA sRNA10702–10736 started, while
expression of small RNAs that mapped to the 3’end of VA RNAII
region reached its highest level. The small RNA VA sRNA11001–11025
seems to target genes involved in metabolic functions, such as
glycan synthesis and fatty acid biosynthesis/metabolism. It is not
easy to see how this would beneﬁt the virus. On the other hand,
TGF signaling pathway was one of the targets, which agrees with
our previous results.
Another important question concerns the substrates from
which the viral small RNAs are excised. Are they cleaved from
VA RNAI and II? Although we lack direct evidence some observa-
tions suggest that they are excised from other precursors than the
VARNAs. First of all, expression of some small RNAs starts very
early, before the VA RNAs are detected. There is, moreover, no
correlation between expression levels of the small RNAs and
expression levels of VA RNAI and II. Secondly, the sequences of
the most highly expressed small RNAs did not completely match
that of VA RNAI. It has been shown that VA RNAI has two
initiations sites, one at nt 10607 [VA RNA(A)] and another at nt
10610 [VA RNA(G)] (Xu et al., 2009). The latter is the major species
and accounts for 75% of total VA RNAI. Our results showed that VA
sRNA10607–10631 was the major species and accounted for 99% of
small RNAs that mapped to the 5’end of VA RNAI during the early
phase of infection. Furthermore, several small RNAs that mapped
to the 3’ end of VA RNA extend beyond the 3´ends of the VA RNAs.
Lastly, from a structural point of view it would not be expected
that a small RNA is generated from the central domain of a
precursor. Therefore it seems unlikely that sRNA10702–10736 is
excised from VA RNAI. Thus, we propose that adenovirus-
encoded small RNAs are produced from a different set of VA RNAs
which are subjected to very efﬁcient cleavage soon after they are
produced.Cellular gene expression is regulated by complex networks. The
adenovirus-encoded small RNAs are likely to be a part of these
networks. The rapid expression of VA sRNA10607–10631, suggested
an important function in the early phase of the infection. Our
previous microarray studies showed that the regulation of host gene
expression in response to the incoming virus is very rapid. Eighteen
cellular genes were up-regulated already at 1 hpi (Granberg et al.,
2006). Eight out of twelve annotated genes encoded transcription
factors that are implicated in cell growth arrest (ATF3, ATF4, KLF4,
KLF6, ELK3 and GABPB2), as well as antiviral immune response and
apoptosis (CEBPB and NR4A1). In addition, the signal regulators
RGS4 and ARHE were also up-regulated. RGS4 is a small GTPase
activating protein and ARHE is a member of the small GTPase
protein superfamily. Regulation of cellular gene expression during
this period must be independent of adenoviral gene expression and
is likely to be triggered by the attachment of the virus to cell surface
receptors, the entry process of the virus, its intracellular transport
along the microtubules or the possible intracellular recognition of
viral nucleic acids by Toll-like receptors. MAPK cascades are key
components of the signaling networks that sense cellular exposure
to environmental stress. Most of the up-regulated genes are either
involved in this pathway or are downstream targets. However,
activation of these immediate response genes is transient and their
expression had decreased at 6 hpi. An important question is how
the earliest host cell anti-viral response is repressed? Although it is
well established that E1A is the ﬁrst viral gene to be transcribed,
they are ﬁrst detected at 12 hpi in IMR-90 cell used in our studies.
E1A cannot thus be responsible for the suppression of host cell
immediate anti-viral response. We show here that some small
RNAs, particularly, VA sRNA10607–10631 are expressed already at
6 hpi Furthermore, we show here that Ad VA sRNA10607–10631 are
likely to target genes involved in diverse signaling pathways,
including the MAPK pathway. Further support for this notion, was
the ﬁnding that many predicted targets, especially those involved in
signaling pathways were down-regulated as revealed by cDNA
sequencing. The adenovirus-encoded small RNAs may thus con-
stitute the front-line defense and be crucial for the survival of
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